Ionis Pharmaceuticals Inc
F:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
Tsuruha Holdings Inc
TSE:3391
|
JP |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
P
|
Prudential Financial Inc
DUS:PLL
|
US |
|
K
|
Kinross Gold Corp
F:KIN2
|
CA |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 79.81 EUR with a low forecast of 35.49 EUR and a high forecast of 104.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
79.81
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 79.81 EUR with a low forecast of 35.49 EUR and a high forecast of 104.27 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
